COVID-19 UNLOCKING INDIA’S CAPACITY IN LIFE SCIENCES Today, for India, the COVID-19 pandemic is a strong catalyst to re-inforce the Make in India initiative to facilitate investment, promote innovation, enhance skill development, protect intellectual property and build best in class manufacturing infrastructure in the life sciences sector. For fostering an innovation ecosystem or hub within India, interventions across three dimensions will be required which includes encouraging industryacademia collaboration; increasing R&D investment; and reinvigorating government support